Amerise Biosciences Ltd

📊 Amerise Biosciences: Net Profit ₹1,60,973, Zero Revenue from Operations

- Net profit: ₹1,60,973 for year ended 31 Mar 2026

- No revenue from operations in FY 2025-26

- No significant business activities during the year

- No fixed assets, inventory, or permanent employees

- Loans given: ₹304.03 Lakhs, investments: ₹376.97 Lakhs

- Non-compliance with certain SEBI LODR regulations

- No subsidiaries, joint ventures, or associate companies

- No cash losses in current or previous financial year

- No default in repayment of loans or borrowings

- No dividend recommended for the year